Titlebook: Atlas of Rheumatoid Arthritis; Paul Emery Book 2015 Springer Healthcare 2015 Arthritis.DMARD.Rheumatoid arthritis.Rheumatology.Rheumatolog

intangibility

Pre-rheumatoid arthritisical and very early clinical disease stages are used; ‘pre-RA’ is one of these terms. In order to facilitate communication, a European League Against Rheumatism (EULAR) task force has derived recommendations for terminology to be used during the preclinical and earliest clinically apparent phases of

ineffectual

Early rheumatoid arthritis of about 3:1 and although age of onset is commonly over 50?years, it may occur at any age [2, 4]. It is a systemic autoimmune disease with predominant joint involvement and typically presents with involvement of the small joints of the hands and feet. Untreated, the disease has been associated with

Nostalgia

Established rheumatoid arthritisRA), including some manifestations such as severe deformities that are rarely seen in clinical practice because the clinical presentation of established RA has substantially changed over the last two decades. The change in clinical presentation is largely due to the use of disease-modifying antirheu

眉毛

Magnetic resonance imaging in rheumatoid arthritisllows assessment of all structures involved in rheumatoid arthritis (RA). MRI is more sensitive than clinical examination and conventional radiography (X-ray) for detecting inflammation and joint damage. Compared to ultrasonography (US), MRI provides better storage and documentation of findings, all

Crayon

Ultrasound imaging in rheumatoid arthritisarly in those with recent disease onset. In these cases, rheumatologists may need further support to look for joint or tendon involvement and suitably objective imaging technique available in everyday practice that can assist with diagnosing joint involvement has long been awaited. Ultrasound (US) i

表示向前

Indecisive

惰性氣體

ffective, early treatment is vital as this can slow the course of the disease and reduce joint damage. RA is usually treated using disease-modifying anti-rheumatic drugs (DMARDs), most commonly methotrexate. The newest treatments target the disease-causing immune elements specifically and directly.978-1-907673-90-0978-1-907673-91-7